WVXU: High-intensity focused ultrasound a new treatment option for men with prostate cancer
According to the Centers for Disease Control and Prevention, prostate cancer is the second-most common cancer in American men after skin cancer. Prostate cancer is more likely to develop in older men and non-Hispanic Black men.
September is Prostate Cancer Awareness Month, and the University of Cincinnati's Abhinav Sidana joined WVXU's Cincinnati Edition program and podcast to discuss a new treatment being offered at UC.
Sidana said that high-intensity focused ultrasound uses sound waves transmitted through an ultrasound transducer to target and kill cancer cells in the prostate.
"By localizing the cancer and destroying just a single spot, we minimize the complications," said Sidana, associate professor and director of urologic oncology at the University of Cincinnati College of Medicine’s Division of Urology and a UC Health urologist. "So men don't lose erections, men don’t become incontinent, there are no cuts on the body. It’s an outpatient, two-hour long procedure and they go home without anything because they’re not in pain."
Listen to the Cincinnati Edition segment.
Featured photo of Dr. Sidana. Photo/Colleen Kelley/UC Marketing + Brand.
Related Stories
‘Designer drug’ shows early neuroprotective signal in acute ischemic stroke
October 28, 2025
Medscape highlighted new trial results led by the University of Cincinnati's Eva Mistry that found an experimental drug shows promise in protecting injured brain cells for patients with acute ischemic stroke.
UC Board votes to fund design for YMCA renovation
October 28, 2025
At its October 28, 2025 meeting, the University of Cincinnati Board of Trustees approved $5 million in funding to complete all design and pre-construction services required to renovate the interior of a former YMCA building located at 270 Calhoun Street.
Is menstrual fluid ‘the most overlooked opportunity’ in women’s health?
October 27, 2025
The Guardian recently reported that period blood has long been thought of as ‘stinky and useless’, but startups are exploring using the fluid to test for a wide range of health conditions — including endometriosis.